Sepp Hochreiter, Djork-Arné Clevert,
"Copy Number Aberrations Affecting the Developing Cerebellar Vermis are Associated with Autism Spectrum Disorders"
: HGV 2011 Proceedings, 2011
Copy Number Aberrations Affecting the Developing Cerebellar Vermis are Associated with Autism Spectrum Disorders
Sprache des Titels:
HGV 2011 Proceedings
Motivation: We investigated neurodevelopmental dysfunctions in autism spectrum disorders
(ASD) by a integrative analysis including the two largest genome wide studies on associations
between copy number aberrations (CNA) and ASD, the "BioGPS" tissue atlas, the "Allen Brain
Atlas", and in situ hybridization histochemistry data from the developing mouse brain. In
contrast to the original association studies, we considered "ASD candidate genes" each of
which is the only CNA impaired gene in an ASD case, therefore, p resumably causing ASD. For
extracting ASD candidate genes, we developed an analysis pipeline for rare and small CNAs.
Rare CNAs are supposed to be more disease-specific, because CNAs that cause ASD with high
probability are assumed to be de novo and quickly vanish in the population due to their low
reproductive fitness. Small CNAs affect only few genes and, therefore, are very specific
concerning the genes they are impairing.
Results: At data from the ?BioGPS?, the ?Cancer Genome Anatomy Project?, and the ?Allen
Brain Atlas?, ASD candidate genes have significantly different variations in their expression
values in cerebellum compared to other genes, where at the ?Allen Brain Atlas? cerebellar
vermis lobes I-II, III, VI, and VIII where most significant. In situ hybridization histochemistry data
indicate that ASD candidate genes are primarily expressed in the developing mouse
Gene set enrichment analysis of ASD candidate genes showed that significant biological
processes are all related to cell and synaptic adhesion and significant cellular components are
postsynaptic density, membrane and synapse. ASD candidate genes that are indentified
independently in both CNA studies include the neurexins CNTNAP2 and NRXN1, the catenin
CTNNA3, the cadherin CDH13, and the contactins CNTN5 and CNTN6.